Skip to content

RENOVACARE, INC.: 10-K filed 2014-03-28

What RENOVACARE, INC. reported in its annual report filed 2014-03-28 (fiscal FY 2013): 22 published measures, 53 facts as tagged in accession 0001477932-14-001298.

This filing

Form
10-K (annual report)
Filed
2014-03-28
Fiscal period
fiscal FY 2013
Accession
0001477932-14-001298 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All RENOVACARE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-311,752,927USD
At 2012-12-311,065,834USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-3155,440USD
At 2012-12-3198,075USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-311,697,486USD
At 2012-12-31967,759USD
At 2011-12-311,211,718USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-311,508,843USD
At 2013-02-19500,144USD
At 2012-12-31513,595USD
At 2011-12-31787,771USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-02-20 to 2013-12-31-1,068,310USD315
2013-01-01 to 2013-12-31-1,032,788USD365
2012-01-01 to 2012-12-31-243,959USD366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-02-20 to 2013-12-31-333,447USD315
2013-01-01 to 2013-12-31-349,898USD365
2012-01-01 to 2012-12-31-267,214USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-02-20 to 2013-12-311,505,000USD315
2013-01-01 to 2013-12-311,505,000USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-02-20 to 2013-12-31-162,854USD315
2013-01-01 to 2013-12-31-159,854USD365
2012-01-01 to 2012-12-31-6,962USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2013-12-31-4,455,482USD
At 2012-12-31-4,491,004USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-01-01 to 2013-12-3163,401,149shares365
2012-01-01 to 2012-12-3163,075,122shares366

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-02-20 to 2013-12-3115,440USD315
2013-01-01 to 2013-12-3115,440USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-311,510,073USD
At 2012-12-31521,957USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-12-3155,440USD
At 2012-12-3140,543USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2013-12-31162,854USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-02-20 to 2013-12-31614,729USD315
2013-01-01 to 2013-12-31628,545USD365
2012-01-01 to 2012-12-31229,539USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-3166,575,122shares
At 2012-12-3163,075,122shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-12-317,220,612USD
At 2012-12-315,462,236USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-12-31-4,104USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2013-02-20 to 2013-12-31-1,064,206USD315
2013-01-01 to 2013-12-31-1,028,684USD365
2012-01-01 to 2012-12-31-243,959USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-02-20 to 2013-12-31614,729USD315
2013-01-01 to 2013-12-31628,545USD365
2012-01-01 to 2012-12-31229,539USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2013-02-20 to 2013-12-31-3,801USD315
2013-01-01 to 2013-12-31-800USD365
2012-01-01 to 2012-12-31-13,714USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-02-20 to 2013-12-3120,256USD315
2013-01-01 to 2013-12-3118,104USD365
2012-01-01 to 2012-12-31-33,150USD366

Inspect the source

Entity
RENOVACARE, INC. / CIK 0001016708
Captured
SEC response SHA-256
9487b64abbea883e1831cb5c68f7e4fad6892ca4a6b733f29ee7e3c3b50f65e4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001016708.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))